Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-053676)

Filing Details

Accession Number:: 0001209191-14-053676
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-08-20 16:54:39
Reporting Period:: 2014-08-18

Filing Date:: 2014-08-20
Accepted Time:: 2014-08-20 16:54:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1479290	Revance Therapeutics Inc.	RVNC	Pharmaceutical Preparations (2834)	770551645

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1597580	Jacob Waugh	C/O Revance Therapeutics, Inc. 7555 Gateway Boulevard Newark CA 94560	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-08-18	25,000	$24.47	53,333	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.230 to $24.830, inclusive.